Abbott Laboratories
In Joel Greenblatt's portfolio · Gotham Asset Management
Ticker ABT
Not in the portfolio as of Q2 2026. Every quarter it shows up in a Gotham Asset Management 13F, newest first.
| Quarter | Activity | Shares | Weight |
|---|---|---|---|
| Q3 2022 | Reduce 11% | 102,865 | 0.3% |
| Q2 2022 | Add 4% | 115,158 | 0.4% |
| Q1 2022 | Add 87% | 110,809 | 0.4% |
| Q1 2018 | Reduce 30% | 600,639 | 0.5% |
| Q4 2017 | Add 4704% | 857,483 | 0.7% |
| Q4 2016 | Buy | 1,010,598 | 0.5% |
| Q1 2016 | Add 772% | 861,862 | 0.4% |
| Q3 2015 | Add 39% | 1,455,289 | 0.6% |
Price is the position's value divided by its shares, at the end of each quarter. Share counts are as filed; when a stock split happened, the change is measured on split-adjusted shares.